Sopharma AD (BUL:SFA)
6.62
+0.02 (0.30%)
At close: Jun 23, 2025
Sopharma AD Revenue
Sopharma AD had revenue of 644.07M BGN in the quarter ending March 31, 2025, with 25.43% growth. This brings the company's revenue in the last twelve months to 2.27B, up 17.44% year-over-year. In the year 2024, Sopharma AD had annual revenue of 2.14B with 13.27% growth.
Revenue (ttm)
2.27B
Revenue Growth
+17.44%
P/S Ratio
0.49
Revenue / Employee
372.20K
Employees
5,599
Market Cap
1.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.14B | 250.64M | 13.27% |
Dec 31, 2023 | 1.89B | 217.31M | 13.00% |
Dec 31, 2022 | 1.67B | 60.17M | 3.73% |
Dec 31, 2021 | 1.61B | 165.21M | 11.42% |
Dec 31, 2020 | 1.45B | 158.02M | 12.27% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shelly Group SE | 220.30M |
Tchaikapharma High Quality Medicines AD | 55.97M |
Speedy AD | 525.58M |
First Investment Bank AD | 456.76M |
Eurohold Bulgaria AD | 3.03B |
Smart Organic AD | 99.16M |
M+S Hydraulic AD | 142.25M |
Holding Varna AD | 88.88M |